Neelapu; Sattva S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Neelapu; Sattva S..The latest application filed is for "anti-cd79b antibodies and chimeric antigen receptors and methods of use thereof".
- Neelapu; Sattva S. - Houston TX
- Neelapu; Sattva S. - Pearland TX
| Patent | Date |
|---|---|
| Anti-cd79b Antibodies And Chimeric Antigen Receptors And Methods Of Use Thereof App 20210317209 - Chu; Fuliang ; et al. | 2021-10-14 |
| T Cell Receptors For Immunotherapy App 20210130431 - WENG; Jinsheng ; et al. | 2021-05-06 |
| TCL1 peptides for immunotherapy Grant 9,290,541 - Neelapu , et al. March 22, 2 | 2016-03-22 |
| Tumor-specific Gm-csf Cytokine Response As Predictor Of Cancer Vaccine Effectiveness App 20140363456 - Wilson; Wyndham H. ; et al. | 2014-12-11 |
| Tcl1 Peptides For Immunotherapy App 20140348902 - Neelapu; Sattva S. ; et al. | 2014-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 